ME00059B - Oksidekahidronaftalen modulatori hm74 - Google Patents

Oksidekahidronaftalen modulatori hm74

Info

Publication number
ME00059B
ME00059B MEP-2008-170A MEP2008170A ME00059B ME 00059 B ME00059 B ME 00059B ME P2008170 A MEP2008170 A ME P2008170A ME 00059 B ME00059 B ME 00059B
Authority
ME
Montenegro
Prior art keywords
oxydecahydronaphthalene
modulators
oxidase
molecules
formula
Prior art date
Application number
MEP-2008-170A
Other languages
English (en)
Inventor
Anne Minnich
Theresa Kuntzweiler
Haifeng Eishingdrelo
Michael Angelastro
Stephan Henke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ME00059B publication Critical patent/ME00059B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)

Abstract

Ćelije domaćina u kojima se pojavljuje HM74 se koriste za dobijanje molekula sličnih oksidekalinu sa aktivnošću agoniste koje imaju sledeću strukturu (formula I).
MEP-2008-170A 2004-02-20 2005-02-10 Oksidekahidronaftalen modulatori hm74 ME00059B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54601204P 2004-02-20 2004-02-20
PCT/US2005/004095 WO2005082352A1 (en) 2004-02-20 2005-02-10 Oxydecahydronaphthalene modulators of hm74
EP05713199A EP1718293A1 (en) 2004-02-20 2005-02-10 Oxydecahydronaphthalene modulators of hm74

Publications (1)

Publication Number Publication Date
ME00059B true ME00059B (me) 2010-06-10

Family

ID=34910747

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-170/08A MEP17008A (en) 2004-02-20 2005-02-10 Oxydecahydronaphthalene modulators of hm74
MEP-2008-170A ME00059B (me) 2004-02-20 2005-02-10 Oksidekahidronaftalen modulatori hm74

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MEP-170/08A MEP17008A (en) 2004-02-20 2005-02-10 Oxydecahydronaphthalene modulators of hm74

Country Status (21)

Country Link
US (2) US7264937B2 (me)
EP (1) EP1718293A1 (me)
JP (1) JP2007526917A (me)
KR (1) KR101145693B1 (me)
CN (1) CN1929833A (me)
AR (1) AR047708A1 (me)
AU (1) AU2005216878B2 (me)
BR (1) BRPI0507916A (me)
CA (1) CA2556757C (me)
CR (1) CR8537A (me)
EC (1) ECSP066776A (me)
IL (1) IL177106A (me)
MA (1) MA28368A1 (me)
ME (2) MEP17008A (me)
NO (1) NO20064214L (me)
RS (1) RS20060472A (me)
RU (1) RU2006133539A (me)
TN (1) TNSN06235A1 (me)
TW (1) TWI354552B (me)
WO (1) WO2005082352A1 (me)
ZA (1) ZA200606687B (me)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094572B2 (en) * 2003-03-14 2006-08-22 Bristol-Myers Squibb Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
ES2435790T3 (es) 2004-12-03 2013-12-23 Intervet International B.V. Piperazinas sustituidas como antagonistas de CB1
EP1973877A2 (en) * 2006-01-18 2008-10-01 Schering Corporation Cannibinoid receptor modulators
WO2008130616A2 (en) * 2007-04-19 2008-10-30 Schering Corporation Diaryl morpholines as cb1 modulators
CA2694264A1 (en) * 2007-06-28 2009-01-08 Intervet International B.V. Substituted piperazines as cb1 antagonists
BRPI0814806A2 (pt) * 2007-06-28 2015-02-03 Intervet Int Bv Pirazinas substituídas como antagonistas de cb1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5674908A (en) * 1993-12-20 1997-10-07 Life Technologies, Inc. Highly packed polycationic ammonium, sulfonium and phosphonium lipids
DE19624154A1 (de) 1996-06-18 1998-01-08 Hoechst Ag Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
EP1007563A4 (en) * 1997-06-12 2003-04-16 Smithkline Beecham Corp HM74A RECEPTOR
GB0021484D0 (en) * 2000-09-01 2000-10-18 Boehringer Ingelheim Pharma Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases

Also Published As

Publication number Publication date
CA2556757C (en) 2011-05-03
RU2006133539A (ru) 2008-03-27
US7264937B2 (en) 2007-09-04
JP2007526917A (ja) 2007-09-20
ZA200606687B (en) 2008-02-27
MEP17008A (en) 2010-06-10
WO2005082352A1 (en) 2005-09-09
AU2005216878A1 (en) 2005-09-09
RS20060472A (en) 2008-11-28
US20080045586A1 (en) 2008-02-21
CR8537A (es) 2007-03-05
IL177106A (en) 2012-03-29
AR047708A1 (es) 2006-02-08
AU2005216878B2 (en) 2010-06-17
KR101145693B1 (ko) 2012-05-25
MA28368A1 (fr) 2006-12-01
TNSN06235A1 (en) 2007-12-03
KR20060127982A (ko) 2006-12-13
ECSP066776A (es) 2006-11-16
TW200539864A (en) 2005-12-16
US20050187263A1 (en) 2005-08-25
NO20064214L (no) 2006-09-18
EP1718293A1 (en) 2006-11-08
TWI354552B (en) 2011-12-21
CA2556757A1 (en) 2005-09-09
IL177106A0 (en) 2006-12-10
BRPI0507916A (pt) 2007-07-10
CN1929833A (zh) 2007-03-14

Similar Documents

Publication Publication Date Title
ATE471324T1 (de) Triazolophthalazine
EA201100125A1 (ru) Производные пирролопиридинилпиримидин-2-иламина
ME00059B (me) Oksidekahidronaftalen modulatori hm74
BRPI0606379A2 (pt) triazolftalazinas
EA200701771A1 (ru) Низкомолекулярные ингибиторы mdm2 и их применение
GT200600035A (es) Aminopiridinas como inhibidores de beta-secretasa
DE602008004397D1 (de) Neuartige Elektroden
EA201100880A1 (ru) Бензонафтиридиновые соединения в качестве ингибиторов аутотаксина
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
ATE520769T1 (de) Enzymatische hydrolyse von biomassen mit hohem dm (dry matter)-gehalt
NO20064237L (no) Furosemide modulatorer for HM74
EA201170051A1 (ru) Гетероциклическое соединение и его применение
BRPI0613770A2 (pt) anticorpos anti-cd26 e métodos de uso destes
CR9956A (es) Metodos y composiciones para modular la hemostasia
EA200870515A1 (ru) Моноциклические гетероарильные соединения
BRPI0912229A2 (pt) mistura para remoção de oxigênio, composição, artigo, mistura padrão, e, uso de uma mistura
CR9853A (es) Compuestos de exemestano (s)-6-metiloxaalquilo y metodos relacionados con su utilizacion
BRPI0502534A (pt) Gel perfluoroelastomérico, processo para formar géis perfluoroelastoméricos, perfluoroelastÈmeros reticuláveis e curados, artigos manufaturados, e, uso de gel
BRPI0508471A8 (pt) compostos de hidróxi-6-fenilfenantidinas substituídas por difluoroetóxi, composição farmacêutica e uso para a produção dos mesmos
DE602005007241D1 (de) 2-amino-benzimidazolderivate und ihre verwendung als modulatoren calciumaktivierter kaliumkanäle mit geringer leitfähigkeit
DE602007006541D1 (de) Verwendung von wassergräsern als träger für erdbodenlose kultivierung und so gebildeter träger
EA200800144A1 (ru) МОДИФИКАЦИИ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ
MX2009006549A (es) Compuestos de amonio cuaternario con modo de accion novedoso para la proteccion de estructuras de madera.
SV2010003755A (es) Nuevos derivados de (piperazinilo con enlaces puente)-1-alcanona y su utilizacion como inhibidores de p75
WO2006104751A3 (en) Methods and compositions for modulating rho-mediated gene transcription